Sun Pharma is weighing the acquisition of US-based Organon in a deal valued at about $10 billion, a move that would ...

India’s biggest medicine-making company, Sun Pharmaceutical Industries, is planning to acquire a US company called Organon.

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved ...

India's largest drugmaker, Sun Pharma, is contemplating a $10 billion acquisition of US-based women’s health specialist, Organon, to strengthen its presence in the American market.

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Danish dermatology specialist Leo Pharma and its CEO Christophe Bourdon came to San Francisco to attend the J.P. Morgan ...

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...

HRV Pharma’s innovative “virtual manufacturing” model connects FDA-approved facilities to prevent prescription shortages and ...

From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time ...

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...